vs
NATURES SUNSHINE PRODUCTS INC（NATR）とONESPAWORLD HOLDINGS Ltd（OSW）の財務データ比較。上の社名をクリックして会社を切り替えられます
ONESPAWORLD HOLDINGS Ltdの直近四半期売上が大きい（$242.1M vs $123.8M、NATURES SUNSHINE PRODUCTS INCの約2.0倍）。ONESPAWORLD HOLDINGS Ltdの純利益率が高く（5.0% vs 3.3%、差は1.7%）。ONESPAWORLD HOLDINGS Ltdの前年同期比売上増加率が高い（11.5% vs 4.7%）。ONESPAWORLD HOLDINGS Ltdの直近四半期フリーキャッシュフローが多い（$14.9M vs $7.6M）。過去8四半期でONESPAWORLD HOLDINGS Ltdの売上複合成長率が高い（7.1% vs 5.6%）
Natures Sunshine Products, Inc.（通称NSP）は、ハーブ、ビタミン、ミネラルを含む栄養補助食品やスキンケアなどのパーソナルケア製品の製造を行っています。本社はユタ州リーハイに置き、同州スパニッシュフォークに生産拠点を構えています。
NATR vs OSW — 直接比較
売上が大きい
OSW
2.0倍大きい
$123.8M
売上成長率が高い
OSW
+6.7%の差
4.7%
純利益率が高い
OSW
純利益率が1.7%高い
3.3%
フリーキャッシュフローが多い
OSW
FCF $7.3M多い
$7.6M
2年売上CAGRが高い
OSW
2年複合成長率
5.6%
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $123.8M | $242.1M |
| 純利益 | $4.1M | $12.1M |
| 粗利率 | 72.5% | — |
| 営業利益率 | 4.3% | 6.8% |
| 純利益率 | 3.3% | 5.0% |
| 売上前年比 | 4.7% | 11.5% |
| 純利益前年比 | 1379.4% | -16.2% |
| EPS（希薄化後） | $0.23 | $0.12 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
売上NATROSW
| Q4 25 | $123.8M | $242.1M | ||
| Q3 25 | $128.3M | $258.5M | ||
| Q2 25 | $114.8M | $240.7M | ||
| Q1 25 | $113.2M | $219.6M | ||
| Q4 24 | $118.2M | $217.2M | ||
| Q3 24 | $114.6M | $241.7M | ||
| Q2 24 | $110.6M | $224.9M | ||
| Q1 24 | $111.0M | $211.2M |
純利益NATROSW
| Q4 25 | $4.1M | $12.1M | ||
| Q3 25 | $5.3M | $24.3M | ||
| Q2 25 | $5.3M | $19.9M | ||
| Q1 25 | $4.7M | $15.3M | ||
| Q4 24 | $-321.0K | $14.4M | ||
| Q3 24 | $4.3M | $21.6M | ||
| Q2 24 | $1.3M | $15.8M | ||
| Q1 24 | $2.3M | $21.2M |
粗利率NATROSW
| Q4 25 | 72.5% | — | ||
| Q3 25 | 73.3% | — | ||
| Q2 25 | 71.7% | — | ||
| Q1 25 | 72.1% | — | ||
| Q4 24 | 72.0% | — | ||
| Q3 24 | 71.3% | — | ||
| Q2 24 | 71.4% | — | ||
| Q1 24 | 71.2% | — |
営業利益率NATROSW
| Q4 25 | 4.3% | 6.8% | ||
| Q3 25 | 7.0% | 10.2% | ||
| Q2 25 | 3.7% | 9.2% | ||
| Q1 25 | 5.4% | 7.7% | ||
| Q4 24 | 3.8% | 7.9% | ||
| Q3 24 | 4.6% | 10.3% | ||
| Q2 24 | 5.1% | 8.4% | ||
| Q1 24 | 4.2% | 8.0% |
純利益率NATROSW
| Q4 25 | 3.3% | 5.0% | ||
| Q3 25 | 4.2% | 9.4% | ||
| Q2 25 | 4.6% | 8.3% | ||
| Q1 25 | 4.2% | 7.0% | ||
| Q4 24 | -0.3% | 6.6% | ||
| Q3 24 | 3.8% | 8.9% | ||
| Q2 24 | 1.2% | 7.0% | ||
| Q1 24 | 2.1% | 10.0% |
EPS（希薄化後）NATROSW
| Q4 25 | $0.23 | $0.12 | ||
| Q3 25 | $0.30 | $0.23 | ||
| Q2 25 | $0.28 | $0.19 | ||
| Q1 25 | $0.25 | $0.15 | ||
| Q4 24 | $-0.02 | $0.13 | ||
| Q3 24 | $0.23 | $0.20 | ||
| Q2 24 | $0.07 | $0.15 | ||
| Q1 24 | $0.12 | $0.21 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $93.9M | $16.3M |
| 総負債低いほど良い | — | $84.0M |
| 株主資本純資産 | $161.6M | $542.6M |
| 総資産 | $261.1M | $707.1M |
| 負債/資本比率低いほどレバレッジが低い | — | 0.15× |
8四半期トレンド — 暦四半期で整列
現金・短期投資NATROSW
| Q4 25 | $93.9M | $16.3M | ||
| Q3 25 | $95.6M | $29.6M | ||
| Q2 25 | $81.3M | $35.0M | ||
| Q1 25 | $86.5M | $22.6M | ||
| Q4 24 | $84.7M | $57.4M | ||
| Q3 24 | $78.7M | $48.8M | ||
| Q2 24 | $68.7M | $62.5M | ||
| Q1 24 | $77.8M | $65.4M |
総負債NATROSW
| Q4 25 | — | $84.0M | ||
| Q3 25 | — | $85.2M | ||
| Q2 25 | — | $96.2M | ||
| Q1 25 | — | $97.4M | ||
| Q4 24 | — | $98.6M | ||
| Q3 24 | — | $98.7M | ||
| Q2 24 | — | $123.8M | ||
| Q1 24 | $2.1M | $138.6M |
株主資本NATROSW
| Q4 25 | $161.6M | $542.6M | ||
| Q3 25 | $166.7M | $552.8M | ||
| Q2 25 | $163.7M | $548.3M | ||
| Q1 25 | $167.1M | $530.6M | ||
| Q4 24 | $161.0M | $554.5M | ||
| Q3 24 | $162.6M | $540.1M | ||
| Q2 24 | $156.4M | $532.7M | ||
| Q1 24 | $159.7M | $515.5M |
総資産NATROSW
| Q4 25 | $261.1M | $707.1M | ||
| Q3 25 | $264.8M | $732.6M | ||
| Q2 25 | $254.9M | $731.8M | ||
| Q1 25 | $252.7M | $708.7M | ||
| Q4 24 | $240.9M | $746.4M | ||
| Q3 24 | $245.3M | $734.0M | ||
| Q2 24 | $235.8M | $756.8M | ||
| Q1 24 | $247.3M | $763.6M |
負債/資本比率NATROSW
| Q4 25 | — | 0.15× | ||
| Q3 25 | — | 0.15× | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.18× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.18× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | 0.01× | 0.27× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $9.9M | $20.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $7.6M | $14.9M |
| FCFマージンFCF / 売上 | 6.1% | 6.2% |
| 設備投資強度設備投資 / 売上 | 1.9% | 2.1% |
| キャッシュ転換率営業CF / 純利益 | 2.41× | 1.65× |
| 直近12ヶ月FCF直近4四半期 | $28.8M | $68.4M |
8四半期トレンド — 暦四半期で整列
営業キャッシュフローNATROSW
| Q4 25 | $9.9M | $20.0M | ||
| Q3 25 | $18.5M | $33.2M | ||
| Q2 25 | $4.3M | $20.3M | ||
| Q1 25 | $2.6M | $10.1M | ||
| Q4 24 | $12.2M | $16.6M | ||
| Q3 24 | $9.6M | $28.6M | ||
| Q2 24 | $1.3M | $18.7M | ||
| Q1 24 | $2.2M | $15.0M |
フリーキャッシュフローNATROSW
| Q4 25 | $7.6M | $14.9M | ||
| Q3 25 | $16.8M | $27.6M | ||
| Q2 25 | $3.0M | $17.6M | ||
| Q1 25 | $1.5M | $8.4M | ||
| Q4 24 | $10.0M | $13.2M | ||
| Q3 24 | $7.9M | $27.5M | ||
| Q2 24 | $-2.0M | $17.6M | ||
| Q1 24 | $-1.5M | $13.7M |
FCFマージンNATROSW
| Q4 25 | 6.1% | 6.2% | ||
| Q3 25 | 13.1% | 10.7% | ||
| Q2 25 | 2.6% | 7.3% | ||
| Q1 25 | 1.3% | 3.8% | ||
| Q4 24 | 8.5% | 6.1% | ||
| Q3 24 | 6.9% | 11.4% | ||
| Q2 24 | -1.9% | 7.8% | ||
| Q1 24 | -1.4% | 6.5% |
設備投資強度NATROSW
| Q4 25 | 1.9% | 2.1% | ||
| Q3 25 | 1.3% | 2.2% | ||
| Q2 25 | 1.2% | 1.1% | ||
| Q1 25 | 1.0% | 0.8% | ||
| Q4 24 | 1.9% | 1.5% | ||
| Q3 24 | 1.5% | 0.5% | ||
| Q2 24 | 3.0% | 0.5% | ||
| Q1 24 | 3.3% | 0.6% |
キャッシュ転換率NATROSW
| Q4 25 | 2.41× | 1.65× | ||
| Q3 25 | 3.46× | 1.36× | ||
| Q2 25 | 0.81× | 1.02× | ||
| Q1 25 | 0.55× | 0.66× | ||
| Q4 24 | — | 1.15× | ||
| Q3 24 | 2.21× | 1.33× | ||
| Q2 24 | 0.97× | 1.19× | ||
| Q1 24 | 0.94× | 0.71× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
OSW
| Services | $197.3M | 82% |
| Products | $44.8M | 18% |
